Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19.

RCMI Coordinating Center (RCMI CC)

Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19.

Malek RJ, Bill CA, Vines CM. Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19. Biomed Pharmacother. 2021 Dec; 144:112276.

View in: PubMed

subject areas

Animals
Antiviral Agents
Biological Products
Clinical Trials as Topic
Humans
Immunity
Treatment Outcome

authors with profiles

Charlotte Vines

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support